Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
AmeriTrust receives CAD 35.07 million from warrant exercises

AmeriTrust receives CAD 35.07 million from warrant exercises

BitgetBitget2026/10/06 13:05

AmeriTrust Financial Technologies received gross proceeds of CAD 35.07 million from warrant exercises. Exercised 285,867,642 convertible debenture and LIFE warrants at CAD 0.12, raising CAD 34.3 million. Exercised 15,397,000 broker warrants at CAD 0.05, raising CAD 769,850. Proceeds earmarked to fund additional vehicle lease contracts, support collateral for lease financing facilities, support working capital. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ameritrust Financial Technologies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610060900NEWSFILECNPR____20261006_317633_1) on October 06, 2026, and is solely responsible for the information contained therein.

  • AmeriTrust Financial Technologies received gross proceeds of CAD 35.07 million from warrant exercises.
  • Exercised 285,867,642 convertible debenture and LIFE warrants at CAD 0.12, raising CAD 34.3 million.
  • Exercised 15,397,000 broker warrants at CAD 0.05, raising CAD 769,850.
  • Proceeds earmarked to fund additional vehicle lease contracts, support collateral for lease financing facilities, support working capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ameritrust Financial Technologies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610060900NEWSFILECNPR____20261006_317633_1) on October 06, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21